These mechanistic insights of CIGB-258 may apply to the treatment of patients with sepsis because low HDL-C levels in serum and displacing apoA-I from HDL by serum amyloid A (SAA) are major risk factors for sepsis. The gene discussed is APOA1; the disease is Sepsis.